About Blaze medical devices

About company

Blaze develops technologies that enable integrated and standardized assessments of blood damage, particularly for red blood cells (RBC). The company’s principal product lines include RBC Mechanical Fragilimeter™ systems for testing the mechanical fragility (MF) of red blood cells, and RBC Hemolysis Tester systems which also include the Fragilimeter™ capability. Initial models of these systems are for a wide range of industrial R&D and other research applications, while subsequent lines will target medical applications.